|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Vien Dong Pharmaceutical Joint Stock Company (Công ty cổ phần Dược phẩm Viễn Đông)
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Vien Dong Pharmaceutical Joint Stock Company Headquarters 411 Huỳnh Văn Bánh, Phường 11, Quận Phú Nhuận, Tp.HCM; Ho Chi Minh (municipality); South Eastern Vietnam; 700000 - 760000 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational Financial Auditors: A&C Auditing and Consultancy Company Ltd (2010) Total Employees: 450 Tel: +84 (8) 399-10866 |
|
Company Description |
| Mua bán dược phẩm, mỹ phẩm.Mua bán thực phẩm.Mua bán bao bì.Mua bán trang thiết bị-dụng cụ-vật tư y tế.Mua bán hóa chất (trừ hóa chất có tính độc hại mạnh) |
Company Analysis |
| According to the Individual - Audited financial statement for the third quarter of 2010, total net operating revenues increased with 50.88%, from VND 228,559.43 millions to VND 344,860.21 millions. Operating result increased from VND 38,779.88 millions to VND 43,857.15 millions which means 13.09% change. The results of the period increased 45.58% reaching VND 35,735.83 millions at the end of the period against VND 24,546.51 millions last year. Return on equity (Net income/Total equity) went from 13.61% to 6.35%, the Return On Asset (Net income / Total Asset) went from 6.18% to 2.30% and the Net Profit Margin (Net Income/Net Sales) went from 10.74% to 10.36% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 175.40% compared to 112.61% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.60 to 1.28 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2010 Q3 (non-cons) |
2010 Q2 (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| CBV - Listed Company Financials | CBV - Listed Company Financials | |
| ||
| Unit | Millions | Millions |
| ||
Balance Sheet
| ||
Total Assets |
1,554,116 |
1,370,250 |
| ||
Current Assets |
1,161,297 |
1,054,039 |
| ||
Total Liabilities |
987,662 |
845,466 |
| ||
Shareholders Equity |
563,077 |
521,407 |
| ||
Current Liabilities |
905,644 |
775,626 |
| ||
| * All the accounts are in VND. | ||
Income Statement
| ||
Total Operating Revenue |
347,671 |
393,650 |
| ||
Operational Profit (Loss) |
43,857 |
63,415 |
| ||
Net Profit (Loss) |
35,735 |
57,915 |
| ||
| * All the accounts are in VND. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
2.3% |
4.23% |
| ||
Annualised Return on Assets (ROA) |
9.2% |
16.92% |
| ||
Return on Equity (ROE) |
6.35% |
11.11% |
| ||
Annualised Return on Equity (ROE) |
25.4% |
44.44% |
| ||
Return on Sales (ROS) |
10.36% |
14.62% |
| ||
Gross Profit Margin |
30.57% |
25.56% |
| ||
Operating Profit Margin |
10.36% |
14.62% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
0.42x |
0.47x |
| ||
Inventory Turnover |
0.80x |
1.91x |
| ||
Current asset turnover |
0.30x |
0.38x |
| ||
Fixed-asset turnover |
0.99x |
1.69x |
| ||
Asset Turnover |
0.22x |
0.29x |
| Valuation figures and ratios | ||
| ||
EBITDA |
-19,633 |
-18,859 |
| ||
Enterprise value |
1,867,977 |
2,172,111 |
| ||
Enterprise Value / EBITDA |
-95.14 |
-115.17 |
| ||
Bookvalue (BV) |
340,384 |
345,777 |
| Liquidity Ratios | ||
| ||
Current Ratio |
128.23% |
135.9% |
| ||
Quick ratio |
95.2% |
116.02% |
| ||
Doom's day ratio |
3.07% |
4.48% |
| Leverage Ratios | ||
| ||
Leverage ratio |
157.35% |
162.07% |
| ||
Debt to equity |
175.4% |
162.15% |
| ||
Long Term Debt to Capital |
12.53% |
11.61% |
| ||
Debt / Enterprise Value |
38.19% |
25.78% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
-60.05 |
-87.15 |
| ||
 |